We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.70
Bid: 43.50
Ask: 44.70
Change: -0.20 (-0.45%)
Spread: 1.20 (2.759%)
Open: 44.90
High: 44.90
Low: 43.70
Prev. Close: 44.30
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Netherlands Electronic Money Licence granted

16 Sep 2022 07:00

RNS Number : 6780Z
Argentex Group PLC
16 September 2022
 

16 September 2022

 

Argentex Group PLC

 

("Argentex" or "the Company")

 

Netherlands Electronic Money Licence granted

License provides gateway for Company's EU growth ambitions

 

Argentex Group PLC (AIM: AGFX), the provider of bespoke foreign exchange services to institutions, corporates and high net worth private individuals, is pleased to confirm that the Dutch National Bank has granted Argentex BV, a subsidiary of Argentex, an Electronic Money Institution ("EMI") licence in the Netherlands.

 

The EMI licence underpins the Company's differentiated and uncompromising approach to regulation, enabling it to fully operate in all areas of its planned business and access the growing Dutch market, as well as providing a springboard to further expand across other EU territories over time. The award is a key milestone in the delivery of Argentex's international growth strategy making the Company one of the very few holders of this category of licence in the Netherlands.

 

A supervisory and management board will oversee the affairs of Argentex BV and will be Chaired by Eppo Heemstra. Eppo has extensive experience in international financial services and payments including 25 years at ABN AMRO and several board positions at fintech companies.

 

Harry Adams, Chief Executive Officer, Argentex Group PLC, said: "This is an exciting moment for our business, providing further regulatory validation and creating a proven gateway to Europe via a credible jurisdiction as our internationalisation strategy deepens. Eppo's in-depth sector expertise will be an asset to us as we gather momentum in the Netherlands and further build a long-term sustainable growth strategy built around the success in our home UK market and latent demand for our services in the highly regulated markets of Netherlands, Australia and in time across the EU.

 

"Argentex places regulatory compliance and risk management at the heart of its business strategy and obtaining an EMI licence from a gold standard EU regulator is testament to this unrelenting focus."

 

Eppo Heemstra, Chair of the supervisory board, added: "The Company has a high-quality, resilient business model - anchored by best practice risk management - that is highly scalable and replicable across new jurisdictions. I look forward to helping the Company leverage this significant milestone and implement its ambitious and exciting growth plans as it expands into the European market."

 

For further information, please contact:

 

Argentex Group PLC

 

Harry Adams - Chief Executive Officer

 

Jo Stent - Chief Financial Officer

 

investorrelations@argentex.com

 

FTI Consulting (Financial PR)

 

Ed Berry / Ambrose Fullalove / Jenny Boyd

 

argentex@fticonsulting.com

 

Singer Capital Markets (Nominated Adviser and Broker)

 

Tom Salvesen / James Maxwell / Justin McKeegan

 

020 7496 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKPBDFBKDCCD
Date   Source Headline
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.